REQUEST A DEMO
Total
USD $0.00
Search more companies

Ever Supreme Bio Technology Co., Ltd. (Taiwan, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Ever Supreme Bio Technology Co., Ltd. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Ever Supreme Bio Technology Co., Ltd. develops new drugs for stem cells, cancer immune cells, and provides innovative medical services. The company was founded in 2016 and is headquartered in Taichung City, Taiwan.

Headquarters
4F., No.30, Keya Rd., Daya Dist
Taichung City; Taichung City;

Contact Details: Purchase the Ever Supreme Bio Technology Co., Ltd. report to view the information.

Website: http://www.ever-supreme.com.tw

Basic Information
Total Employees:
Purchase the Ever Supreme Bio Technology Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Ever Supreme Bio Technology Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Ever Supreme Bio Technology Co., Ltd. report to view the information.
Incorporation Date:
December 06, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
14.57%
Purchase this report to view the information.
12.41%
Purchase this report to view the information.
1.49%
Purchase this report to view the information.
1.14%
Purchase this report to view the information.
0.76%
Subsidiaries
SunSage Medical International Co., Ltd.
100%
Shine-On BioMedical Co., Ltd.
8.37%
Ever Fortune.AI CO., Ltd.
1.67%
Company Performance
Financial values in the chart are available after Ever Supreme Bio Technology Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
12.43%
Total operating revenue
13.86%
Operating profit (EBIT)
149.39%
EBITDA
78.51%
Net Profit (Loss) for the Period
525.6%
Total assets
5.52%
Total equity
4.98%
Operating Profit Margin (ROS)
50.53%
Net Profit Margin
71.91%
Return on Equity (ROE)
21.05%
Quick Ratio
-2.62%
Cash Ratio
-0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?